Composition for treatment of displastic processes of uterine cervix

摘要

The invention relates to medicine and the pharmaceutical industry, in particular to new agents for treating dysplastic changes in the uterine cervix and the rectal mucosa. The inventive medicinal agent for treating dysplastic changes in the uterine cervix and the rectal mucosa is in the form of a suppository and is characterized in that it contains 3,3'-diindolylmethane, epigallocatechin-3-gallate, a catalyst of the inhibitory activity of epigallocatechin-3-gallate with respect to DNA methyltransferase, consisting of Mgcations in the form of a pharmaceutically acceptable magnesium salt, a lipophilic base containing solid fat, polyvinylpyrrolidone and butylhydroxyanisole and/or butylhydroxytoluene. The agent is effective against severe dysplastic diseases.